Usnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Launches collaborative centre for translational research in head and neck cancer
Additionally, an MoU was signed between the Dental Council of India and Quality Council of India for the assessment and rating of undergraduate dental colleges
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
New Board of Directors and management team at Suven Pharma also appointed
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
Subscribe To Our Newsletter & Stay Updated
